FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002912054> ?p ?o ?g. }

• W2002912054 endingPage "556" @default.
• W2002912054 startingPage "550" @default.
• W2002912054 abstract "There is considerable unexplained interindividual variability in the clearance of alfentanil. Alfentanil undergoes extensive metabolism by cytochrome P4503A4 (CYP3A4). CYP3A5 is structurally similar to CYP3A4 and metabolizes most CYP3A4 substrates but is polymorphically expressed. Livers with the CYP3A5*1 allele contain higher amounts of the native CYP3A5 protein than livers homozygous for the mutant CYP3A5*3 allele. This investigation tested the hypothesis that alfentanil is a substrate for CYP3A5 and that CYP3A5 pharmacogenetic variability influences human liver alfentanil metabolism.Alfentanil metabolism to noralfentanil and N-phenylpropionamide was determined in microsomes from two groups of human livers, characterized for CYP3A4 and CYP3A5 protein content: low CYP3A5 (2.0-5.2% of total CYP3A, n = 10) and high CYP3A5 (46-76% of total CYP3A, n = 10). Mean CYP3A4 content was the same in both groups. The effects of the CYP3A inhibitors troleandomycin and ketoconazole, the latter being more potent toward CYP3A4, on alfentanil metabolism were also determined.In the low versus high CYP3A5 livers, respectively, noralfentanil formation was 77 +/- 31 versus 255 +/- 170 pmol . min . mg, N-phenylpropionamide formation was 8.0 +/- 3.1 versus 20.5 +/- 14.0 pmol . min . mg, and the metabolite ratio was 9.5 +/- 0.4 versus 12.7 +/- 1.4 (P < 0.05 for all). There was a poor correlation between alfentanil metabolism and CYP3A4 content but an excellent correlation when CYP3A5 (i.e., total CYP3A content) was considered (r = 0.81, P < 0.0001). Troleandomycin inhibited alfentanil metabolism similarly in the low and high CYP3A5 livers; ketoconazole inhibition was less in the high CYP3A5 livers.In microsomes from human livers expressing the CYP3A5*1 allele and containing higher amounts of CYP3A5 protein, compared with those with the CYP3A5*3 allele and little CYP3A5, there was greater alfentanil metabolism, metabolite ratios more closely resembled those for expressed CYP3A5, and inhibitors with differing CYP3A4 and CYP3A5 selectivities had effects resembling those for expressed CYP3A5. Therefore, alfentanil is metabolized by human liver microsomal CYP3A5 in addition to CYP3A4, and pharmacogenetic variability in CYP3A5 expression significantly influences human liver alfentanil metabolism in vitro. Further investigation is warranted to assess whether the CYP3A5 polymorphism is a factor in the interindividual variability of alfentanil metabolism and clearance in vivo." @default.
• W2002912054 created "2016-06-24" @default.
• W2002912054 creator A5004489015 @default.
• W2002912054 creator A5007500532 @default.
• W2002912054 creator A5012844446 @default.
• W2002912054 creator A5023187458 @default.
• W2002912054 date "2005-03-01" @default.
• W2002912054 modified "2023-10-05" @default.
• W2002912054 title "Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5" @default.
• W2002912054 cites W1533470994 @default.
• W2002912054 cites W162702352 @default.
• W2002912054 cites W1846579908 @default.
• W2002912054 cites W1958017720 @default.
• W2002912054 cites W1966881167 @default.
• W2002912054 cites W1967797994 @default.
• W2002912054 cites W1975639237 @default.
• W2002912054 cites W1979150683 @default.
• W2002912054 cites W1980612293 @default.
• W2002912054 cites W1982940569 @default.
• W2002912054 cites W1985984753 @default.
• W2002912054 cites W1987600922 @default.
• W2002912054 cites W1987952101 @default.
• W2002912054 cites W1989739287 @default.
• W2002912054 cites W1993263798 @default.
• W2002912054 cites W1997016310 @default.
• W2002912054 cites W1999259563 @default.
• W2002912054 cites W2004411083 @default.
• W2002912054 cites W2005328285 @default.
• W2002912054 cites W2015509769 @default.
• W2002912054 cites W2017334752 @default.
• W2002912054 cites W2018985419 @default.
• W2002912054 cites W2021775978 @default.
• W2002912054 cites W2021792455 @default.
• W2002912054 cites W2024131514 @default.
• W2002912054 cites W2028603080 @default.
• W2002912054 cites W2032034515 @default.
• W2002912054 cites W2033290892 @default.
• W2002912054 cites W2034728660 @default.
• W2002912054 cites W2051227554 @default.
• W2002912054 cites W2052406081 @default.
• W2002912054 cites W2053378327 @default.
• W2002912054 cites W2055843576 @default.
• W2002912054 cites W2056897801 @default.
• W2002912054 cites W2060317640 @default.
• W2002912054 cites W2069520922 @default.
• W2002912054 cites W2076336531 @default.
• W2002912054 cites W2082076628 @default.
• W2002912054 cites W2083650072 @default.
• W2002912054 cites W2087056538 @default.
• W2002912054 cites W2097502628 @default.
• W2002912054 cites W2099101568 @default.
• W2002912054 cites W2105681476 @default.
• W2002912054 cites W2105902511 @default.
• W2002912054 cites W2126772533 @default.
• W2002912054 cites W2129088448 @default.
• W2002912054 cites W2133016152 @default.
• W2002912054 cites W2136187773 @default.
• W2002912054 cites W2136428431 @default.
• W2002912054 cites W2144059872 @default.
• W2002912054 cites W2157049173 @default.
• W2002912054 cites W2158837711 @default.
• W2002912054 cites W2163879184 @default.
• W2002912054 cites W2164539379 @default.
• W2002912054 cites W2169984670 @default.
• W2002912054 cites W2791969457 @default.
• W2002912054 doi "https://doi.org/10.1097/00000542-200503000-00012" @default.
• W2002912054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15731592" @default.
• W2002912054 hasPublicationYear "2005" @default.
• W2002912054 type Work @default.
• W2002912054 sameAs 2002912054 @default.
• W2002912054 citedByCount "30" @default.
• W2002912054 countsByYear W20029120542013 @default.
• W2002912054 countsByYear W20029120542017 @default.
• W2002912054 countsByYear W20029120542019 @default.
• W2002912054 countsByYear W20029120542022 @default.
• W2002912054 countsByYear W20029120542023 @default.
• W2002912054 crossrefType "journal-article" @default.
• W2002912054 hasAuthorship W2002912054A5004489015 @default.
• W2002912054 hasAuthorship W2002912054A5007500532 @default.
• W2002912054 hasAuthorship W2002912054A5012844446 @default.
• W2002912054 hasAuthorship W2002912054A5023187458 @default.
• W2002912054 hasBestOaLocation W20029120541 @default.
• W2002912054 hasConcept C104317684 @default.
• W2002912054 hasConcept C109650736 @default.
• W2002912054 hasConcept C11824378 @default.
• W2002912054 hasConcept C126322002 @default.
• W2002912054 hasConcept C135763542 @default.
• W2002912054 hasConcept C16005928 @default.
• W2002912054 hasConcept C181199279 @default.
• W2002912054 hasConcept C185592680 @default.
• W2002912054 hasConcept C2776277131 @default.
• W2002912054 hasConcept C2777477808 @default.
• W2002912054 hasConcept C2779548794 @default.
• W2002912054 hasConcept C2781064554 @default.
• W2002912054 hasConcept C2781091344 @default.
• W2002912054 hasConcept C526171541 @default.
• W2002912054 hasConcept C55493867 @default.
• W2002912054 hasConcept C55775858 @default.

• next